Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in Utero
Ousseny Zerbo(Kaiser Permanente), Nicola P. Klein, Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), James G. Donahue(Brigham and Women's Hospital), Candace C. Fuller(Harvard University), A. Patricia Wodi, Edwin Lewis(Kaiser Permanente), Michael M. McNeil(Centers for Disease Control and Prevention), Kristin Palmsten(University of California San Diego), Sharareh Modaressi(Kaiser Permanente Oakland Medical Center), Kristin Goddard(Kaiser Permanente Oakland Medical Center), Darios Getahun(Kaiser Permanente), Bradley Crane, Matthew F. Daley(Kaiser Permanente)
Cited by 10
Related Papers
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602